People Will Become More Accepting Of Jabs: Expert
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576240_1_20210218165956.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-02-18 HKT 17:16
Dr Leung Chi-chiu speaks to Wendy Wong
A specialist in respiratory medicine said on Thursday that he believed more people would be willing to receive coronavirus vaccine once the inoculation programme is rolled out, although various surveys suggested a low acceptance rate.
Previous polls showed only between 30 and 40 per cent of Hong Kong people would get the jabs, but Dr Leung Chi-chiu said he believed their attitude would change over time.
He said he expected the public to become less worried about the vaccine’s safety as more people get inoculated.
“For something new, I think the initial acceptance may be low. That should not be a major issue because the priority groups account for about 2.4 million people. And we only have sufficient vaccine in the initial stage for one million,” he said.
“If we can roll out the programme successfully, I’m certain that the attitude will change with time. As time goes, there will be further data not only from abroad but also from the local application. That should relieve the anxiety of people who might be worried about the vaccine’s safety profile.”
He noted that an expert panel appointed by the government has yet to decide on whether the vaccine produced by mainland drug maker Sinovac can be given to elderly people aged over 60.
He said the decision would affect how quickly protection could be offered to elderly people living in care homes here.
“This is crucial because this vaccine does not require the super cold storage syringe. They can be more easily handled by the outreach teams. If they can be applied for the elderly, they can be quickly utilised to cover our old age homes,” he said.
SBI Holdings To Acquire Bitbank In US$289M Crypto Expansion
SBI Holdings has agreed to acquire Japanese crypto exchange Bitbank in a deal valued at approximately US$289 million, w... Read more
4 Ways Hong Kong Banks Fight Financial Crime Using AI, According To HKMA
The Hong Kong Monetary Authority (HKMA) wants banks to use AI in financial crime as a way to counter cyberattacks and s... Read more
Ripple Launches RLUSD Stablecoin In Japan Through SBI Group
Ripple has launched its US dollar-denominated stablecoin, Ripple USD, in the Japanese market. The expansion follows reg... Read more
SBI And Startale Launch Trust Bank-Backed Yen Stablecoin JPYSC In Japan
SBI Group has introduced its trust based stablecoin JPYSC in partnership with Singapore-based fintech company Startale ... Read more
Visa Study: Digital Wallets Lead Greater Bay Area Payment Preferences
Visa has released its latest Consumer Payment Attitudes Study, highlighting how payment seamlessness is linked to a shi... Read more
European And South Korean Banks Form Project Pangea For FX Settlement
Chainlink, South Korean infrastructure provider FairSquareLab, the Unified Korea Alliance (UniKA), and European stablec... Read more
